Following positive trial findings , retatrutide, a new peptide option for treating non-insulin dependent hyperglycemia , has received official approval from UK’s Drug and Healthcare Agency ( MHRA https://larissalmqf465245.blogspothub.com/39747490/retatrutide-medication-peptide-british-green-light-and-access